He has also represented Valeant Pharmaceuticals International, a company in which Mr. Ackman is a major investor and which is being investigated by the S. E. C. over potential accounting irregularities. Mr. Clayton, who says he will recuse himself from certain cases involving former clients, has also personally invested in a number of hedge funds and private equity firms through special Sullivan  Cromwell investment vehicles, according to the filing. He earned $7. 6 million from Sullivan   Cromwell over the past year or so and has investments in portfolios managed by Apollo Global Management, Bain Capital, J. C. Flowers and Perry Partners. 